MALIGNANT SOLID NEOPLASM
Clinical trials for MALIGNANT SOLID NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID NEOPLASM trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer Patients' COVID-19 trial halted after just 4 participants
Disease control TerminatedThis early-stage study tested two drugs, rintatolimod and interferon alpha-2b, in cancer patients with COVID-19. The goal was to see if the combination could boost the immune system to fight the virus. Only 4 people took part before the study was stopped early. The main focus was…
Matched conditions: MALIGNANT SOLID NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
Cancer treatment side effect study halted after just one patient
Disease control TerminatedThis study looked at whether two drugs, infliximab and intravenous immunoglobulin (IVIG), could help cancer patients with severe lung inflammation (pneumonitis) that didn't get better with steroids. The goal was to improve oxygen levels in the blood after 28 days. However, the st…
Matched conditions: MALIGNANT SOLID NEOPLASM
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 06, 2026 16:13 UTC
-
Can tech boost depression treatment in cancer care?
Symptom relief TerminatedThis study looked at whether adding technology to collaborative care management helps cancer patients with depression. It involved 297 adults receiving cancer treatment at urban and rural centers. The goal was to see if tech-enhanced care improves treatment engagement and reduces…
Matched conditions: MALIGNANT SOLID NEOPLASM
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated May 11, 2026 20:50 UTC
-
New program aims to ease emotional toll of cancer on families
Symptom relief TerminatedThis study tested two educational programs for parents with late-stage cancer who have children aged 5 to 17. The programs were designed to help parents talk with their children about cancer and improve family coping. The goal was to reduce parents' anxiety and depression and boo…
Matched conditions: MALIGNANT SOLID NEOPLASM
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated May 07, 2026 18:42 UTC